The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM
Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficiency of an oral regimen in newly diagnosed
Waldenström macroglobulinemia: thalidomide plus cyclophosphamide and dexamethasone following
by thalidomide and prednisone maintenance therapy.